Sheryl Crow teams up with breast cancer center
Musician Sheryl Crow teamed up with the Pink Lotus Breast Center to create the Sheryl Crow Imaging Center, a state-of-the-art breast imaging center based in Los Angeles featuring the latest advancements in digital screening and diagnostic imaging technologies.
Musician Sheryl Crow teamed up with the Pink Lotus Breast Center to create the Sheryl Crow Imaging Center, a state-of-the-art breast imaging center based in Los Angeles featuring the latest advancements in digital screening and diagnostic imaging technologies.
In addition, women will have a variety of onsite options to manage their breast health, including clinical breast exams, diagnostic biopsies, genetic testing, surgery, radiation, nutrition, Chinese medicine, and other ancillary services designed to guide each woman through her cancer treatment in a single location.
Crow was diagnosed with breast cancer in 2006 after a routine mammogram and received her treatment from Dr. Kristi Funk, a breast cancer surgeon and founder of the Pink Lotus Breast Center.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
Contrast-Enhanced Mammography Study Reveals 24 Percent Lower Sensitivity with Moderate/Marked BPE
April 30th 2025In comparison to minimal or mild background parenchymal enhancement on contrast-enhanced mammography (CEM), researchers found that moderate or marked BPE was associated with a 12 percent lower AUC for breast cancer detection.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
